|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.03 CAD | +1.55% |
|
+3.15% | +15.46% |
| 06-19 | Chemtrade Logistics Income Fund Declares June 2026 Distribution | MT |
| 06-19 | Chemtrade Logistics Income Fund Declares Cash Distribution for the Month of June 2026 Payable on July 31, 2026 | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.18 | 6.89 | 8.24 | 7.83 | 7.61 | |||||
Return on Total Capital | 0.23 | 9.09 | 11.06 | 10.47 | 9.93 | |||||
Return On Equity % | -47.73 | 23.07 | 39.16 | 16.64 | 17.5 | |||||
Return on Common Equity | -47.73 | 23.07 | 39.16 | 16.64 | 17.5 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 9.22 | 19.52 | 22.78 | 24.09 | 23.03 | |||||
SG&A Margin | 8.49 | 6.59 | 7.46 | 8.31 | 8.02 | |||||
EBITDA Margin % | 14.47 | 22.19 | 24.32 | 22.76 | 22.61 | |||||
EBITA Margin % | 4.82 | 15.07 | 17.32 | 16.7 | 15.99 | |||||
EBIT Margin % | 0.49 | 12.79 | 15.24 | 15.41 | 14.67 | |||||
Income From Continuing Operations Margin % | -17.19 | 6.02 | 13.5 | 7.1 | 6.98 | |||||
Net Income Margin % | -17.19 | 6.02 | 13.5 | 7.1 | 6.98 | |||||
Net Avail. For Common Margin % | -17.19 | 6.02 | 13.5 | 7.1 | 6.98 | |||||
Normalized Net Income Margin | -4.97 | 5.86 | 9.14 | 6.73 | 7.37 | |||||
Levered Free Cash Flow Margin | 24.36 | 14.2 | 12.12 | 9.72 | 4.24 | |||||
Unlevered Free Cash Flow Margin | 27.47 | 16.24 | 13.78 | 11.49 | 6.54 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.6 | 0.86 | 0.87 | 0.81 | 0.83 | |||||
Fixed Assets Turnover | 1.2 | 1.67 | 1.67 | 1.49 | 1.56 | |||||
Receivables Turnover (Average Receivables) | 14.99 | 16.52 | 13.68 | 12.12 | 11.49 | |||||
Inventory Turnover (Average Inventory) | 11.13 | 11.26 | 10.48 | 10.44 | 11.38 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.53 | 0.92 | 0.8 | 0.42 | 0.9 | |||||
Quick Ratio | 0.26 | 0.52 | 0.46 | 0.22 | 0.54 | |||||
Operating Cash Flow to Current Liabilities | 0.5 | 0.95 | 0.98 | 0.44 | 0.77 | |||||
Days Sales Outstanding (Average Receivables) | 24.36 | 22.1 | 26.67 | 30.19 | 31.77 | |||||
Days Outstanding Inventory (Average Inventory) | 32.8 | 32.4 | 34.84 | 35.05 | 32.08 | |||||
Average Days Payable Outstanding | 37.8 | 37.23 | 42.7 | 43.02 | 39.7 | |||||
Cash Conversion Cycle (Average Days) | 19.35 | 17.27 | 18.81 | 22.22 | 24.14 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 316.28 | 184.19 | 122.17 | 109.89 | 154.69 | |||||
Total Debt / Total Capital | 75.98 | 64.81 | 54.99 | 52.36 | 60.74 | |||||
LT Debt/Equity | 265.97 | 176.14 | 115.2 | 59.21 | 143.13 | |||||
Long-Term Debt / Total Capital | 63.89 | 61.98 | 51.85 | 28.21 | 56.2 | |||||
Total Liabilities / Total Assets | 81.46 | 73.75 | 66.47 | 64.18 | 69.38 | |||||
EBIT / Interest Expense | 0.08 | 3.91 | 4.93 | 5.44 | 3.98 | |||||
EBITDA / Interest Expense | 3.1 | 7.57 | 8.75 | 9.17 | 6.97 | |||||
(EBITDA - Capex) / Interest Expense | 2.02 | 5.63 | 5.83 | 5.5 | 4.57 | |||||
Total Debt / EBITDA | 4.88 | 2.32 | 1.73 | 1.94 | 2.34 | |||||
Net Debt / EBITDA | 4.82 | 2.16 | 1.67 | 1.88 | 2.28 | |||||
Total Debt / (EBITDA - Capex) | 7.5 | 3.13 | 2.6 | 3.23 | 3.56 | |||||
Net Debt / (EBITDA - Capex) | 7.41 | 2.91 | 2.5 | 3.14 | 3.47 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -0.81 | 32.51 | 1.84 | -3.23 | 11.79 | |||||
Gross Profit, 1 Yr. Growth % | 40.59 | 180.54 | 25.01 | 2.35 | 6.86 | |||||
EBITDA, 1 Yr. Growth % | 6.08 | 103.2 | 16.67 | -8.94 | 11.05 | |||||
EBITA, 1 Yr. Growth % | 35.03 | 314.73 | 24.99 | -5.99 | 7.06 | |||||
EBIT, 1 Yr. Growth % | -141.54 | 3.38K | 31.19 | -1.26 | 6.46 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 40.44 | -146.39 | 128.49 | -49.1 | 9.84 | |||||
Net Income, 1 Yr. Growth % | 40.44 | -146.39 | 128.49 | -49.1 | 9.84 | |||||
Normalized Net Income, 1 Yr. Growth % | -32.62 | -256.32 | 76.97 | -18.56 | 22.39 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 27.74 | -142.76 | 53.94 | -31.39 | 16.76 | |||||
Accounts Receivable, 1 Yr. Growth % | 11.72 | 27.85 | 19.05 | 0.95 | 34.84 | |||||
Inventory, 1 Yr. Growth % | 0.18 | 31.89 | -15.25 | 8.03 | 0.31 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -10.08 | 0.39 | 4.02 | 12.87 | 0.46 | |||||
Total Assets, 1 Yr. Growth % | -18.05 | 5.28 | -2.22 | 8.31 | 10.81 | |||||
Tangible Book Value, 1 Yr. Growth % | 57.97 | -90.99 | -932.31 | 64.01 | -84.11 | |||||
Common Equity, 1 Yr. Growth % | -37.3 | 49.06 | 24.89 | 15.73 | -5.28 | |||||
Cash From Operations, 1 Yr. Growth % | -18.93 | 68.55 | 8.74 | -13.37 | 3.8 | |||||
Capital Expenditures, 1 Yr. Growth % | 11.74 | 34.01 | 44.14 | 11.66 | -1.93 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 62.8 | -22.77 | -9.25 | -21.13 | -52.78 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 50.32 | -21.68 | -10.29 | -18.8 | -38.05 | |||||
Dividend Per Share, 1 Yr. Growth % | -14.29 | 0 | 0 | 10 | 4.55 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -5.51 | 14.65 | 16.17 | -0.73 | 4.01 | |||||
Gross Profit, 2 Yr. CAGR % | -12.01 | 98.6 | 82.6 | 13.12 | 4.58 | |||||
EBITDA, 2 Yr. CAGR % | -15.22 | 46.82 | 50.6 | 2.79 | 0.56 | |||||
EBITA, 2 Yr. CAGR % | -30.01 | 136.65 | 120.31 | 7.98 | 0.32 | |||||
EBIT, 2 Yr. CAGR % | -67.2 | 280.01 | 549.44 | 13.31 | 2.53 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 53.63 | -19.28 | 2.96 | 7.85 | -25.23 | |||||
Net Income, 2 Yr. CAGR % | 53.63 | -19.28 | 2.96 | 7.85 | -25.23 | |||||
Normalized Net Income, 2 Yr. CAGR % | 143.55 | 2.63 | 57.58 | 12.29 | -0.16 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 46.32 | -26.09 | -18.86 | 2.77 | -10.5 | |||||
Accounts Receivable, 2 Yr. CAGR % | -21.24 | 19.52 | 23.37 | 9.63 | 16.67 | |||||
Inventory, 2 Yr. CAGR % | -4.4 | 14.95 | 5.73 | -4.32 | 4.1 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -8.85 | -4.99 | 2.19 | 8.36 | 6.49 | |||||
Total Assets, 2 Yr. CAGR % | -14.13 | -7.12 | 1.46 | 2.91 | 9.55 | |||||
Tangible Book Value, 2 Yr. CAGR % | 41.89 | -62.27 | -13.4 | 269.47 | -48.96 | |||||
Common Equity, 2 Yr. CAGR % | -29.28 | -3.32 | 36.44 | 20.22 | 4.7 | |||||
Cash From Operations, 2 Yr. CAGR % | 25.32 | 16.9 | 35.38 | -2.94 | -5.95 | |||||
Capital Expenditures, 2 Yr. CAGR % | -5.42 | 22.37 | 38.98 | 26.87 | 3.02 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 101.44 | 12.13 | -18.07 | -16.07 | -37.97 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 244.57 | 8.51 | -17.74 | -14.91 | -28.09 | |||||
Dividend Per Share, 2 Yr. CAGR % | -29.29 | -7.42 | 0 | 4.88 | 7.24 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -4.99 | 5.76 | 10.21 | 9.3 | 3.28 | |||||
Gross Profit, 3 Yr. CAGR % | -10.64 | 29.51 | 67.36 | 50.56 | 10.99 | |||||
EBITDA, 3 Yr. CAGR % | -13.48 | 13.46 | 34 | 27.11 | 5.47 | |||||
EBITA, 3 Yr. CAGR % | -26.35 | 26.65 | 87.14 | 65.43 | 7.67 | |||||
EBIT, 3 Yr. CAGR % | -57.75 | 55.23 | 159.73 | 245.6 | 10.98 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 21.38 | 3.07 | 14.18 | -18.59 | 8.5 | |||||
Net Income, 3 Yr. CAGR % | 21.38 | 3.07 | 14.18 | -18.59 | 8.5 | |||||
Normalized Net Income, 3 Yr. CAGR % | 84.88 | 110.09 | 18.72 | 20.94 | 15.56 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 17.64 | -2.9 | -5.61 | -23.28 | 7.24 | |||||
Accounts Receivable, 3 Yr. CAGR % | -21.59 | -7.43 | 19.36 | 15.4 | 17.46 | |||||
Inventory, 3 Yr. CAGR % | -8.01 | 6.42 | 3.85 | 6.49 | -2.8 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -5 | -5.87 | -2.08 | 5.63 | 5.66 | |||||
Total Assets, 3 Yr. CAGR % | -10.7 | -8.1 | -5.51 | 3.69 | 5.48 | |||||
Tangible Book Value, 3 Yr. CAGR % | 14.19 | -43.39 | 5.81 | 7.14 | 29.44 | |||||
Common Equity, 3 Yr. CAGR % | -27.98 | -9.33 | 5.29 | 29.15 | 11.04 | |||||
Cash From Operations, 3 Yr. CAGR % | -3.59 | 38.33 | 14.11 | 16.66 | -1.29 | |||||
Capital Expenditures, 3 Yr. CAGR % | -2.3 | 6.23 | 29.24 | 29.21 | 15.22 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 10.86 | 46.33 | 3 | -19.53 | -29.96 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 9.94 | 110.29 | 0.57 | -18.26 | -22.75 | |||||
Dividend Per Share, 3 Yr. CAGR % | -20.63 | -20.63 | -5.01 | 3.23 | 4.77 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.1 | 4.3 | 2.96 | 3.12 | 7.69 | |||||
Gross Profit, 5 Yr. CAGR % | -2.25 | 13.12 | 18.93 | 21.45 | 38.67 | |||||
EBITDA, 5 Yr. CAGR % | -1.19 | 7.01 | 8 | 8.1 | 19.33 | |||||
EBITA, 5 Yr. CAGR % | -10.18 | 12.11 | 14.16 | 17.27 | 45.61 | |||||
EBIT, 5 Yr. CAGR % | -35.67 | 23.94 | 26.04 | 34.74 | 78.76 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 70.74 | 6.72 | 13.65 | 4.95 | -3.6 | |||||
Net Income, 5 Yr. CAGR % | 118.3 | -5.83 | 13.65 | 4.95 | -3.6 | |||||
Normalized Net Income, 5 Yr. CAGR % | 63.95 | 196.29 | 73.43 | 60.02 | 7.85 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 58.66 | 2.44 | 1.39 | -0.67 | -7.6 | |||||
Accounts Receivable, 5 Yr. CAGR % | -5.47 | -10.55 | -6 | -0.95 | 18.28 | |||||
Inventory, 5 Yr. CAGR % | 11.01 | 3.92 | -2.74 | 1.99 | 3.95 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.45 | -2.97 | -2.18 | -0.42 | 1.26 | |||||
Total Assets, 5 Yr. CAGR % | -1.07 | -6.28 | -6.02 | -3.84 | 0.25 | |||||
Tangible Book Value, 5 Yr. CAGR % | -5.65 | -29.94 | 2.23 | 19.88 | -20.95 | |||||
Common Equity, 5 Yr. CAGR % | -13.16 | -13.19 | -7 | 1.5 | 5.05 | |||||
Cash From Operations, 5 Yr. CAGR % | 7.44 | 19.53 | 10.43 | 20.05 | 5.62 | |||||
Capital Expenditures, 5 Yr. CAGR % | 8.69 | 9.02 | 12.49 | 14.05 | 18.03 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 31.86 | 23.55 | -1.77 | 16.15 | -16.18 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 27.42 | 17.01 | -2.1 | 45.33 | -12.17 | |||||
Dividend Per Share, 5 Yr. CAGR % | -12.94 | -12.94 | -12.94 | -11.27 | -0.29 |
- Stock Market
- Stocks
- CHE.UN Stock
- Financials Chemtrade Logistics Income Fund
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















